121 related articles for article (PubMed ID: 38303241)
21. [A Case of Advanced Gastric Cancer with Distant Lymph Nodes Metastasis Showing a Complete Response to Six-Courses Chemotherapy].
Demura K; Murakami K; Yoshida M; Yoneda K; Ohashi T; Osawa H; Ide Y; Morimoto O; Hatanaka N; Nishida T
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2042-2044. PubMed ID: 35045487
[TBL] [Abstract][Full Text] [Related]
22. Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study.
Tabernero J; Hoff PM; Shen L; Ohtsu A; Shah MA; Cheng K; Song C; Wu H; Eng-Wong J; Kim K; Kang YK
Lancet Oncol; 2018 Oct; 19(10):1372-1384. PubMed ID: 30217672
[TBL] [Abstract][Full Text] [Related]
23. [A Case of Recurrent Gastric Cancer of Multiple Organ Metastasis with Long-Term Survival Due to Multimodal Treatment].
Hasegawa T; Kubo N; Sakurai K; Kuroda K; Tashima T; Iseki Y; Murata A; Nishii T; Kodai S; Tachimori A; Shimizu S; Kanazawa A; Inoue T; Nishiguchi Y; Maeda K
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1730-1732. PubMed ID: 36732981
[TBL] [Abstract][Full Text] [Related]
24. [A Case of Unresectable Local Recurrence of Gastric Cancer Successfully Resected after Pre-Operative Chemotherapy with Trastuzumab].
Okubo S; Takahashi T; Miyazaki Y; Makino T; Kurokawa Y; Yamazaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2094-6. PubMed ID: 26805275
[TBL] [Abstract][Full Text] [Related]
25. [A Case of Unresectable Gastric Cancer with Paraaortic Lymph Node Metastasis Treated with Conversion Therapy].
Yamaguchi S; Kanetaka K; Maruya Y; Kobayashi S; Adachi T; Hidaka M; Ito S; Kobayashi K; Eguchi S
Gan To Kagaku Ryoho; 2021 May; 48(5):717-719. PubMed ID: 34006722
[TBL] [Abstract][Full Text] [Related]
26. [HER2-Positive Advanced Gastric Cancer with Para-Aortic Lymph Node Metastases Treated with Conversion Surgery after Chemotherapy-A Case Report].
Furusawa K; Higashida M; Kubota H; Iwamoto R; Kitagawa S; Kinoshita S; Ueno M; Mineta S; Okamoto Y; Watanabe Y; Okada T; Tsuruta A; Fujiwara Y; Ueno T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2533-2535. PubMed ID: 32156989
[TBL] [Abstract][Full Text] [Related]
27. EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
Wagner AD; Grabsch HI; Mauer M; Marreaud S; Caballero C; Thuss-Patience P; Mueller L; Elme A; Moehler MH; Martens U; Kang YK; Rha SY; Cats A; Tokunaga M; Lordick F
BMC Cancer; 2019 May; 19(1):494. PubMed ID: 31126258
[TBL] [Abstract][Full Text] [Related]
28. [Remarkable Response to Trastuzumab Observed in a Case of Gastric Cancer with HER2-Negative Conversion].
Horii N; Morioka D; Yamaguchi K; Sato Y
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1207-1209. PubMed ID: 27760939
[TBL] [Abstract][Full Text] [Related]
29. [A case of HER2-positive advanced gastric cancer successfully treated with a combination of capecitabine, cisplatin, and trastuzumab as first-line chemotherapy].
Deguchi K; Nishikawa K; Iwase K; Kawada J; Aono T; Yoshida H; Nomura M; Tamagawa H; Matsuda C; Deguchi T; Higashi S; Okumura Y; Noguchi Y; Nomura M; Takagi M; Fukui A; Tanaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2253-5. PubMed ID: 24394076
[TBL] [Abstract][Full Text] [Related]
30. Case report: Long response to PD-1 blockade after failure of trastuzumab plus chemotherapy in advanced Epstein-Barr virus-associated gastric cancer.
Pan Y; Lu L; Liu H; Chen D; Han N; Yao R; Wang X; Gao X; Yu J; Chen L; Zhou F; Hao G; Lu Y; Li M; He G; Kang F; Li Z; Tang Y; Zhang J; Wei L; Nie Y
Front Immunol; 2022; 13():1003859. PubMed ID: 36353623
[TBL] [Abstract][Full Text] [Related]
31. [A Case of HER2-Positive Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy with S-1/CDDP/Trastuzumab].
Nishino M; Hosoda Y; Okano M; Nagai K; Yasui M; Kim Y; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2043-5. PubMed ID: 26805258
[TBL] [Abstract][Full Text] [Related]
32. [Two Cases of Complete Response to Trastuzumab Combined with Chemotherapy for Recurrence of HER2-Positive Gastric Cancer].
Iwata M; Tabata M; Nakamura S; Nakamura S; Segi Y; Fujimura Y; Desaki R; Kobayashi M; Ohsawa I; Kato K; Sanda T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2404-2406. PubMed ID: 32156946
[TBL] [Abstract][Full Text] [Related]
33. [Two cases of human epidermal growth factor receptor 2-positive advanced gastric cancer successfully treated with S-1, cisplatin, and trastuzumab combination therapy followed by curative resection].
Yasuyama A; Mikata S; Soma Y; Yoshikawa Y; Watase C; Kubota M; Miyake Y; Matsuura Y; Kim HM; Murakami M; Hirota M; Morishima H; Matsunami N; Hasegawa J; Miwa H; Nezu R
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2203-6. PubMed ID: 24394060
[TBL] [Abstract][Full Text] [Related]
34. [A Case of HER-2 Positive Advanced Gastric Cancer Responding to Capecitabine＋Cisplatin＋Trastuzumab Chemotherapy].
Segami K; Sato T; Kawabe T; Hayashi S; Makuuchi Y; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1295-7. PubMed ID: 26489577
[TBL] [Abstract][Full Text] [Related]
35. [Complete Response of Liver Metastases from a HER2-Positive Gastric Cancer Treated with Combined S-1/Trastuzumab Chemotherapy].
Oae S; Shimada S; Takano Y; Seki J; Nakahara K; Maeda C; Takehara Y; Enami Y; Sawada N; Ishida F; Kudo S
Gan To Kagaku Ryoho; 2020 May; 47(5):831-834. PubMed ID: 32408330
[TBL] [Abstract][Full Text] [Related]
36. [A Case of HER2-Positive Gastric Cancer with Multiple Liver Metastases Treated with Curative Conversion Therapy after Chemotherapy].
Kato Y; Natsuki S; Iimori N; Okuno T; Kametani N; Noda E; Yamamoto A; Yamada N; Nishimura S; Taenaka N; Matsunaga Y; Fujita S
Gan To Kagaku Ryoho; 2020 Apr; 47(4):682-684. PubMed ID: 32389983
[TBL] [Abstract][Full Text] [Related]
37. Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy.
Dong CX; Fu JF; Ye XY; Li XF; Zhong X; Yuan Y
World J Gastroenterol; 2014 Sep; 20(34):12355-8. PubMed ID: 25232273
[TBL] [Abstract][Full Text] [Related]
38. [Two cases of stage IV gastric cancer treated by resection of the primary tumor after chemotherapy combined with trastuzumab].
Nakayama Y; Kawasaki H; Wajima N; Kimura A; Nakai M; Yonaiyama S; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2188-90. PubMed ID: 24394055
[TBL] [Abstract][Full Text] [Related]
39. A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group Study.
Abali H; Yalcin S; Onal HC; Dane F; Oksuzoglu B; Ozdemir N; Mertsoylu H; Artac M; Camci C; Karabulut B; Basal FB; Budakoglu B; Sendur MAN; Goktas B; Ozdener F; Baygul A
Am J Clin Oncol; 2021 Jul; 44(7):301-307. PubMed ID: 33979100
[TBL] [Abstract][Full Text] [Related]
40. [Two Cases of HER2-Positive Gastric Cancer with Multiple Liver Metastases Leading to Conversion Therapy with Chemotherapy].
Ono HA; Kaneshiro M; Nakashima M; Baba H; Abe T; Kumagai J; Sugita M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1662-1664. PubMed ID: 29394735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
